Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166334 · ClinicalTrials.gov registry record · Phase 1
WebQuit Online Smoking Cessation Study
A Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 721
- Enrollment target
NCT01166334 is a Phase 1 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 721 participants.
The verdict
NCT01166334, a Phase 1 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 721 participants
- Enrollment target
Study Summary
Would you like to quit smoking? Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn which of these programs is the most effective at helping people stop smoking. Findings from this study will be used to help build more effective online smoking cessation programs in the future. Participants in both of the smoking cessation programs used in this study will receive: * Interactive tools for dealing more effectively with urges to smoke * Step-by-step guides for quitting smoking * Personalized plans for quitting and remaining smoke-free * Electronic links for reaching one-on-one expert help for quitting Participants will be asked to complete online questionnaires, including a brief three-month follow-up survey. There is no cost for participating in this study. To enroll in this study or for more information, please visit www.webquit.com. This study is being conducted by Seattle's Fred Hutchinson Cancer Research Center (www.fhcrc.org), a world leader in advancing the prevention, diagnosis and treatment of cancer. The principal investigator for the WebQuit smoking cessation study is Dr. Jonathan Bricker, a faculty member at both the Hutchinson Center and at the University of Washington in Seattle.
Interventions
- BEHAVIORAL WebQuit study group
- BEHAVIORAL WebQuit control group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 721 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01166334
The ClinicalTrials.gov registry entry for NCT01166334 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 721 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which WebQuit study group is the first listed.
NCT01166334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01166334 about?
NCT01166334 is a clinical study titled "WebQuit Online Smoking Cessation Study". Would you like to quit smoking? Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn wh...
What is the current status of trial NCT01166334?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 721 participants. The study started on 2010-06. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01166334?
The interventions under investigation include: WebQuit study group (BEHAVIORAL), WebQuit control group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01166334?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.